Winners of EFIC Grunenthal Pain Research Grant 2023 Announced
The European Pain Federation EFIC® and the pharmaceutical company Grünenthal have announced the three recipients of the EFIC-Grünenthal Grant (E-G-G). With a total value of €100,000, this biennial grant rewards innovative projects for human pain research and supports...
Our second quarterly EFIC Newsletter is available!
The latest quarterly newsletter of the European Pain Federation EFIC has just been published. Check out our latest updates on the #EFIC2023 Congress, the EFIC Academy, our Research and Advocacy activities, news from our Chapters and much more. Read it...
#EFIC2023 Programme Spotlight: Cancer Pain
Cancer pain is a common and often debilitating symptom experienced by cancer patients. Effective management of cancer pain is essential in improving the quality of life for these patients and is a crucial aspect of cancer care. With the growing number of cancer...
#EFIC2023 Programme Spotlight: Special Patient Groups
Pain management is a critical aspect of healthcare, and providing effective pain relief is essential for promoting patient comfort, improving quality of life, and optimizing overall health outcomes. However, managing pain in special patient groups, such as children...
